The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Leukotriene modifiers as potential therapeutics for cardiovascular disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Self-citationLeukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Ford-Hutchinson, A. W., Bray, M. A., Doig, M. V., Shipley, M. E., & Smith, M. J. H. (1980) · Nature · doi:10.1038/286264a0 · Cited by 2,060
Cox, B. M., Opheim, K. E., Teschemacher, H., & Goldstein, A. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90272-6 · Cited by 1,708
Lewis (1990) · doi:10.1056/nejm199009063231006 · Cited by 1,200
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Brennan, M.-L., Penn, M. S., Van Lente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035003 · Cited by 1,070
Dahlén, S. E., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
Murphy, R. C., Hammarström, S., & Samuelsson, B. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4275 · Cited by 991
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D.-S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) · Nature · doi:10.1038/21658 · Cited by 965
Leukotrienes are potent constrictors of human bronchi
Dahlén, S.-E., Hedqvist, P., Hammarström, S., & Samuelsson, B. (1980) · Nature · doi:10.1038/288484a0 · Cited by 958
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
Helgadottir, A., Manolescu, A., Thorleifsson, G., Gretarsdottir, S., Jonsdottir, H., Thorsteinsdottir, U., Samani, N. J., Gudmundsson, G., Grant, S. F. A., Thorgeirsson, G., et al. (2004) · Nature Genetics · doi:10.1038/ng1311 · Cited by 927
Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., & Keppler, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46856-1 · Cited by 853
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
Dixon, R. A. F., Diehl, R. E., Opas, E., Rands, E., Vickers, P. J., Evans, J. F., Gillard, J. W., & Miller, D. K. (1990) · Nature · doi:10.1038/343282a0 · Cited by 774
Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime
Steinberg, D. (2002) · Nature Medicine · doi:10.1038/nm1102-1211 · Cited by 679
Characterization of the Human Cysteinyl Leukotriene 2 Receptor
Heise, C. E., O'Dowd, B. F., Figueroa, D. J., Sawyer, N., Nguyen, T., Im, D.-S., Stocco, R., Bellefeuille, J. N., Abramovitz, M., Cheng, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003490200 · Cited by 658
Brocklehurst, W. E. (1960) · The Journal of Physiology · doi:10.1113/jphysiol.1960.sp006449 · Cited by 634
Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro.
Drazen, J. M., Austen, K. F., Lewis, R. A., Clark, D. A., Goto, G., Marfat, A., & Corey, E. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4354 · Cited by 626
Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis
Dwyer, J. H., Allayee, H., Dwyer, K. M., Fan, J., Wu, H., Mar, R., Lusis, A. J., & Mehrabian, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa025079 · Cited by 619
Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease
Blankenberg, S., Rupprecht, H. J., Bickel, C., Torzewski, M., Hafner, G., Tiret, L., Smieja, M., Cambien, F., Meyer, J., & Lackner, K. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030535 · Cited by 596
The Role of Leukotrienes in Inflammation
Henderson, W. R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-9-199411010-00010 · Cited by 586
Drazen, J. M., Yandava, C. N., Dubé, L., Szczerback, N., Hippensteel, R., Pillari, A., Israel, E., Schork, N., Silverman, E. S., Katz, D. A., et al. (1999) · Nature Genetics · doi:10.1038/9680 · Cited by 560
Leff, J. A., Busse, W. W., Pearlman, D., Bronsky, E. A., Kemp, J., Hendeles, L., Dockhorn, R., Kundu, S., Zhang, J., Seidenberg, B. C., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807163390302 · Cited by 552
A Second Leukotriene B4 Receptor, Blt2
Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.421 · Cited by 538
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
Self-citationIdentification and isolation of a membrane protein necessary for leukotriene production
Miller, D. K., Gillard, J. W., Vickers, P. J., Sadowski, S., Léveillé, C., Mancini, J. A., Charleson, P., Dixon, R. A. F., Ford-Hutchinson, A. W., Fortin, R., et al. (1990) · Nature · doi:10.1038/343278a0 · Cited by 459
Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 458
Robbiani, D. F., Finch, R. A., Jäger, D., Muller, W. A., Sartorelli, A. C., & Randolph, G. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00179-3 · Cited by 454
Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Glass, C. K., Sigal, E., Witztum, J. L., & Steinberg, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6959 · Cited by 426
Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422
Self-citationLeukotriene B4 receptor BLT1 mediates early effector T cell recruitment
Tager, A. M., Bromley, S. K., Medoff, B. D., Islam, S. A., Bercury, S. D., Friedrich, E. B., Carafone, A. D., Gerszten, R. E., & Luster, A. D. (2003) · Nature Immunology · doi:10.1038/ni970 · Cited by 419
A Role for Cysteinyl Leukotrienes in Airway Remodeling in a Mouse Asthma Model
HENDERSON, W. R., TANG, L.-O., CHU, S.-J., TSAO, S.-M., CHIANG, G. K. S., JONES, F., JONAS, M., PAE, C., WANG, H., & CHI, E. Y. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.1.2105051 · Cited by 418
Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Sigal, E., Särkioja, T., Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115111 · Cited by 379
The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry Air
Israel, E., Dermarkarian, R., Rosenberg, M., Sperling, R., Taylor, G., Rubin, P., & Drazen, J. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012203232505 · Cited by 370
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm
Zhao, L., Moos, M. P. W., Gräbner, R., Pédrono, F., Fan, J., Kaiser, B., John, N., Schmidt, S., Spanbroek, R., Lötzer, K., et al. (2004) · Nature Medicine · doi:10.1038/nm1099 · Cited by 354
Self-citationLeukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues
Goodarzi, K., Goodarzi, M., Tager, A. M., Luster, A. D., & von Andrian, U. H. (2003) · Nature Immunology · doi:10.1038/ni972 · Cited by 354
In, K. H., Asano, K., Beier, D., Grobholz, J., Finn, P. W., Silverman, E. K., Silverman, E. S., Collins, T., Fischer, A. R., Keith, T. P., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119241 · Cited by 334
Leukotrienes: Underappreciated Mediators of Innate Immune Responses
Peters-Golden, M., Canetti, C., Mancuso, P., & Coffey, M. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.589 · Cited by 329
Gillard, J. W., Ford‐Hutchinson, A. W., Chan, C.-C., Charleson, S. E., Denis, D., Foster, A., Fortin, R., Léger, S., McFarlane, C. S., Morton, H. E., et al. (1989) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y89-073 · Cited by 324
Mast cell–dependent migration of effector CD8+ T cells through production of leukotriene B4
Ott, V. L., Cambier, J. C., Kappler, J., Marrack, P., & Swanson, B. J. (2003) · Nature Immunology · doi:10.1038/ni971 · Cited by 284
Bailie, M. B., Standiford, T. J., Laichalk, L. L., Coffey, M. J., Strieter, R., & Peters-Golden, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5221 · Cited by 273
Leukotriene A4 hydrolase in human leukocytes. Purification and properties.
Rådmark, O., Shimizu, T., Jörnvall, H., & Samuelsson, B. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90750-7 · Cited by 268
Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.
Folcik, V. A., Nivar-Aristy, R. A., Krajewski, L. P., & Cathcart, M. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118062 · Cited by 252
Rouzer, C. A., & Samuelsson, B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6040 · Cited by 250
Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice
Aiello, R. J., Bourassa, P.-A., Lindsey, S., Weng, W., Freeman, A., & Showell, H. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105593 · Cited by 247
Knapp, H. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012203232506 · Cited by 239
Hakonarson, H., Thorvaldsson, S., Helgadottir, A., Gudbjartsson, D., Zink, F., Andresdottir, M., Manolescu, A., Arnar, D. O., Andersen, K., Sigurdsson, A., et al. (2005) · JAMA · doi:10.1001/jama.293.18.2245 · Cited by 236
Cyrus, T., Praticò, D., Zhao, L., Witztum, J. L., Rader, D. J., Rokach, J., FitzGerald, G. A., & Funk, C. D. (2001) · Circulation · doi:10.1161/01.cir.103.18.2277 · Cited by 232
Self-citationHelgadottir, A., Gretarsdottir, S., St. Clair, D., Manolescu, A., Cheung, J., Thorleifsson, G., Pasdar, A., Grant, S. F. A., Whalley, L. J., Hakonarson, H., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/428066 · Cited by 232
Gimbrone, M. A., Brock, A. F., & Schafer, A. I. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111570 · Cited by 218
Michelassi, F., Landa, L., Hill, R. D., Lowenstein, E., Watkins, W. D., Petkau, A. J., & Zapol, W. M. (1982) · Science · doi:10.1126/science.6808665 · Cited by 217
Characterization of the human 5-lipoxygenase gene.
Funk, C. D., Hoshiko, S., Matsumoto, T., Rdmark, O., & Samuelsson, B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2587 · Cited by 212
Self-citationRole of Leukotriene B4Receptors in the Development of Atherosclerosis: Potential Mechanisms
Subbarao, K., Jala, V. R., Mathis, S., Suttles, J., Zacharias, W., Ahamed, J., Ali, H., Tseng, M. T., & Haribabu, B. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000110503.16605.15 · Cited by 208
Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey
Smedegård, G., Hedqvist, P., Dahlén, S.-E., Revenäs, B., Hammarström, S., & Samuelsson, B. (1982) · Nature · doi:10.1038/295327a0 · Cited by 204
Huo, Y., Zhao, L., Hyman, M. C., Shashkin, P., Harry, B. L., Burcin, T., Forlow, S. B., Stark, M. A., Smith, D. F., Clarke, S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143628.37680.f6 · Cited by 196
Self-citation12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor–Deficient Mice
George, J., Afek, A., Shaish, A., Levkovitz, H., Bloom, N., Cyrus, T., Zhao, L., Funk, C. D., Sigal, E., & Harats, D. (2001) · Circulation · doi:10.1161/hc3901.095772 · Cited by 194
Self-citationInvolvement of 15-lipoxygenase in early stages of atherogenesis.
Kühn, H., Belkner, J., Zaiss, S., Fährenklemper, T., & Wohlfeil, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.6.1903 · Cited by 193
Hui, K. P., Taylor, I. K., Taylor, G. W., Rubin, P., Kesterson, J., Barnes, N. C., & Barnes, P. J. (1991) · Thorax · doi:10.1136/thx.46.3.184 · Cited by 185
Adams, G. K., & Lichtenstein, L. M. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.2.555 · Cited by 184
ALOX5AP Gene and the PDE4D Gene in a Central European Population of Stroke Patients
Lõhmussaar, E., Gschwendtner, A., Mueller, J. C., Org, T., Wichmann, E., Hamann, G., Meitinger, T., & Dichgans, M. (2005) · Stroke · doi:10.1161/01.str.0000157587.59821.87 · Cited by 184
DiPersio, J. F., Billing, P., Williams, R., & Gasson, J. C. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4315 · Cited by 183
Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans
Cipollone, F., Mezzetti, A., Fazia, M. L., Cuccurullo, C., Iezzi, A., Ucchino, S., Spigonardo, F., Bucci, M., Cuccurullo, F., Prescott, S. M., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000172632.96987.2d · Cited by 173
Carry, M., Korley, V, Willerson, J. T., Weigelt, L., Ford-Hutchinson, A. W., & Tagari, P. (1992) · Circulation · doi:10.1161/01.cir.85.1.230 · Cited by 172
5-Lipoxygenase: A Target for Antiinflammatory Drugs Revisited
Steinhilber, D. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220207211259 · Cited by 146
Characterization of the human 5-lipoxygenase gene promoter.
Hoshiko, S., Rådmark, O., & Samuelsson, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9073 · Cited by 139
Antileukotrienes in the Treatment of Asthma
O’Byrne, P. M., Israel, E., & Drazen, J. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-6-199709150-00009 · Cited by 136
The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitor
Bell, R. L., Young, P. R., Albert, D. H., Lanni, C., Summers, J. B., Brooks, D. W., Rubin, P. D., & Carter, G. W. (1992) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(92)90182-k · Cited by 131
Silverman, E. S., Du, J., Sanctis, G. T. D., Rådmark, O., Samuelsson, B. O., Drazen, J. M., & Collins, T. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.2.3154 · Cited by 123
5-Lipoxygenase and atherosclerosis
Mehrabian, M., & Allayee, H. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00005 · Cited by 118
Razin, E., Mencia‐Huerta, J. M., Lewis, R. A., Corey, E. J., & Austen, K. F. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4665 · Cited by 116
Leukotrienes and the cardiovascular system
Feuerstein, G. (1984) · Prostaglandins · doi:10.1016/0090-6980(84)90015-7 · Cited by 103
Zhao, L., Cuff, C. A., Moss, E., Wille, U., Cyrus, T., Klein, E. A., Praticò, D., Rader, D. J., Hunter, C. A., Puré, E., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205738200 · Cited by 103
Self-citationGene characterization and promoter analysis of the human 5-lipoxygenase-activating protein (FLAP)
Kennedy, B. P., Diehl, R. E., Boie, Y., Adam, M., & Dixon, R. A. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93004-8 · Cited by 93
Welch, C. L., Seidelmann, S. B., Latib, N., Bezouevski, M., Guo, Y., Pleskac, N., Liang, C.-P., Barlow, C. B., Dansky, H. M., Breslow, J. L., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141239098 · Cited by 93
Roberts, W., Simon, T., Berlin, R., Haggitt, R., Snyder, E., Stenson, W. F., Hanauer, S., Reagan, J., Cagliola, A., Tanaka, W., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041233 · Cited by 90
Genetic Locus in Mice That Blocks Development of Atherosclerosis Despite Extreme Hyperlipidemia
Mehrabian, M., Wong, J., Wang, X., Jiang, Z., Shi, W., Fogelman, A. M., & Lusis, A. J. (2001) · Circulation Research · doi:10.1161/hh1401.093458 · Cited by 84
At last, direct evidence that lipoxygenases play a role in atherogenesis
Steinberg, D. I. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7298 · Cited by 81
Evans, J. F., Lévillé, C., Mancini, J. A., Prasit, P., Thérien, M., Zamboni, R. J., GAUTHIER, J. Y., Fortin, R., Charleson, P., & MacIntyre, D. E. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12843-5 · Cited by 76
The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes.
Lam, B. K., Gagnon, L., Austen, K. F., & Soberman, R. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77365-1 · Cited by 64
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
Rask-Madsen, J., Bukhave, K., Laursen, L., & Lauritsen, K. (1992) · PubMed · Cited by 62
Transcellular metabolism of eicosanoids.
Aj, M. (1986) · PubMed · Cited by 47
Genetic Variations in the 5-Lipoxygenase Core Promoter: Description and Functional Implications
Silverman, E. S., & Drazen, J. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_1.ltta-16 · Cited by 46
STRAIF, D., Werz, O., Kellner, R., Bahr, U., & Steinhilber, D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490455 · Cited by 44
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease
Rask-Madsen, J., Bukhave, K., Laursen, L., & Lauritsen, K. (1992) · Inflammation Research · doi:10.1007/bf01991022 · Cited by 38
Activation of the human neutrophil 5‐lipoxygenase by leukotriene B 4
McDonald, P. P., McColl, S. R., Naccache, P. H., & Borgeat, P. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14491.x · Cited by 35
Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
Ab, K. (1983) · PubMed · Cited by 29
Kühn, H., Anton, M., Gerth, C., & Habenicht, A. J. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000074167.01184.48 · Cited by 28
Gene Suggests Asthma Drugs May Ease Cardiovascular Inflammation
Wickelgren, I. (2004) · Science · doi:10.1126/science.303.5660.941a · Cited by 17
Biochemistry and physiology of the leukotrienes
Barnes, N. C., & Smith, L. J. (1999) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02737595 · Cited by 16
Aneurysms: leukotrienes weaken aorta from the outside
Palinski, W. (2004) · Nature Medicine · doi:10.1038/nm0904-896 · Cited by 12
Role of leukotrienes in antimicrobial host defense of the lung
Peters-Golden, M. L., & Coffey, M. (1999) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02737609 · Cited by 12
Cited by
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease
Haeggström, J. Z., & Funk, C. D. (2011) · Chemical Reviews · doi:10.1021/cr200246d · Cited by 875
Self-citationArita, M., Ohira, T., Sun, Y.-P., Elangovan, S., Chiang, N., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3912 · Cited by 633
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
Shimizu, K., Mitchell, R. N., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000214999.12921.4f · Cited by 627
Anti-inflammatory therapies for cardiovascular disease
Ridker, P. M., & Luscher, T. F. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu203 · Cited by 550
Metadata
- Authors
- Funk, C. D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-07-22
- Volume
- 4
- Issue
- 8
- Pages
- 664-672
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2090578197
- Cited by
- 326
- References
- 94
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.